molecular docking

In Silico and In Vitro anticancer activity of isolated novel marker compound from chemically modified bioactive fraction from Curcuma longa (NCCL)

Naqvi A, Malasoni R, Gupta S, Srivastava A, Pandey RR, Dwivedi AKumar. In Silico and In Vitro anticancer activity of isolated novel marker compound from chemically modified bioactive fraction from Curcuma longa (NCCL). Pharmacognosy Magazine [Internet]. 2017;13(51s):s640-s644. https://www.ncbi.nlm.nih.gov/pubmed/29142426